Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-11-16 Sale |
2022-11-18 5:23 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
14,470 | $11.13 | $161,051 | 186,561 (Direct) |
View |
2022-09-14 Sale |
2022-09-16 4:21 pm |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
10,800 | $10.28 | $111,024 | 44,988 (Direct) |
View |
2022-07-15 Sale |
2022-07-19 5:16 pm |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
3,600 | $9.05 | $32,580 | 15,476 (Direct) |
View |
2022-07-15 Sale |
2022-07-19 5:13 pm |
Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director |
7,200 | $9.05 | $65,160 | 25,076 (Direct) |
View |
2022-04-01 Sale |
2022-04-05 5:51 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
1,642 | $11.91 | $19,556 | 102,344 (Direct) |
View |
2022-04-01 Sale |
2022-04-05 5:50 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
1,642 | $11.91 | $19,556 | 74,893 (Direct) |
View |
2022-04-01 Sale |
2022-04-05 5:49 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
1,784 | $11.91 | $21,247 | 169,781 (Direct) |
View |
2022-04-04 Sale |
2022-04-05 5:48 pm |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
2,006 | $12.67 | $25,416 | 201,031 (Direct) |
View |
2022-03-03 Sale |
2022-03-04 5:54 pm |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
2,044 | $11.38 | $23,261 | 37,811 (Direct) |
View |
2022-03-03 Sale |
2022-03-04 5:51 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
1,787 | $11.38 | $20,336 | 103,986 (Direct) |
View |
2022-02-25 Sale |
2022-03-01 4:19 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
1,972 | $10.29 | $20,292 | 145,773 (Direct) |
View |
2022-02-25 Sale |
2022-03-01 4:16 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
2,114 | $10.29 | $21,753 | 211,565 (Direct) |
View |
2022-02-25 Sale |
2022-03-01 4:14 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
1,972 | $10.29 | $20,292 | 156,535 (Direct) |
View |
2021-11-12 Sale |
2021-11-16 6:15 pm |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
8,180 | $16.04 | $131,207 | 7,200 (Direct) |
View |
2021-11-01 Sale |
2021-11-03 4:55 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
1,000 | $17.15 | $17,150 | 45,900 (Direct) |
View |
2021-10-27 Sale |
2021-10-28 6:34 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
1,000 | $15 | $15,000 | 46,900 (Direct) |
View |
2021-09-07 Sale |
2021-09-09 4:48 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T President & CEO |
20,000 | $15.47 | $309,400 | 991,405 (Direct) |
View |
2021-08-30 Sale |
2021-09-01 6:09 pm |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
1,759 | $14.2 | $24,978 | 70,917 (Direct) |
View |
2021-08-30 Sale |
2021-09-01 6:08 pm |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
1,982 | $14.2 | $28,144 | 3,352 (Direct) |
View |
2021-08-30 Sale |
2021-09-01 6:07 pm |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
3,847 | $14.2 | $54,627 | 141,072 (Direct) |
View |
2021-08-30 Sale |
2021-09-01 6:06 pm |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
2,110 | $14.2 | $29,962 | 47,900 (Direct) |
View |
2021-08-30 Sale |
2021-09-01 6:04 pm |
Cara Therapeutics Inc. | CARA | CHALMERS DEREK T President & CEO |
8,440 | $14.2 | $119,848 | 1,011,405 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-09-12 Option Award |
2022-09-14 4:42 pm |
N/A 2032-09-12 |
Cara Therapeutics Inc. | CARA | Maynard Ryan D Chief Financial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
2022-06-15 Option Award |
2022-06-16 5:14 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Makara Richard VP, Head of Accting;Controller |
7,500 | $0 | 13,583 (Direct) |
View |
Ownership |
2022-06-16 5:12 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Makara Richard VP, Head of Accting;Controller |
0 | $0 | 176,083 (Direct) |
View |
2022-06-02 Option Award |
2022-06-06 5:52 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | Shiff Susan Ph.D. Director |
28,872 | $0 | 36,072 (Direct) |
View |
2022-06-02 Option Award |
2022-06-06 5:51 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | Ives Jeffrey L. Director |
28,872 | $0 | 36,072 (Direct) |
View |
2022-06-02 Option Award |
2022-06-06 5:50 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | BAINS HARRISON M JR Director |
28,872 | $0 | 49,272 (Direct) |
View |
2022-06-02 Option Award |
2022-06-06 5:49 pm |
N/A 2032-06-02 |
Cara Therapeutics Inc. | CARA | VOGELBAUM MARTIN Director |
69,621 | $0 | 89,781 (Direct) |
View |
2022-02-25 Option Award |
2022-03-01 4:19 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
65,333 | $0 | 145,773 (Direct) |
View |
2022-02-28 Option Award |
2022-03-01 4:18 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
5,333 | $10.29 | 79,855 (Direct) |
View |
2022-02-25 Option Award |
2022-03-01 4:18 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
60,000 | $0 | 79,855 (Direct) |
View |
2022-02-25 Option Award |
2022-03-01 4:17 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Posner Christopher President and CEO |
160,000 | $0 | 324,037 (Direct) |
View |
2022-02-25 Option Award |
2022-03-01 4:16 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
60,000 | $0 | 211,565 (Direct) |
View |
2022-02-25 Option Award |
2022-03-01 4:14 pm |
N/A 2032-02-25 |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
100,000 | $0 | 156,535 (Direct) |
View |
2021-12-17 Option Award |
2021-12-21 5:32 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D |
12,607 | $0 | 153,679 (Direct) |
View |
2021-12-17 Option Award |
2021-12-21 5:29 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Goncalves Joana Chief Medical Officer |
12,607 | $0 | 58,507 (Direct) |
View |
2021-12-17 Option Award |
2021-12-21 5:28 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Terrillion Scott Sec'y; Chief Compliance & G.C. |
11,495 | $0 | 82,412 (Direct) |
View |
2021-12-17 Option Award |
2021-12-21 5:26 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
11,170 | $0 | 14,522 (Direct) |
View |
2021-10-29 Option Award |
2021-11-03 08:15 am |
N/A 2031-10-29 |
Cara Therapeutics Inc. | CARA | Posner Christopher Senior Advisor |
713,941 | $0 | 730,037 (Direct) |
View |
Ownership |
2021-10-21 4:30 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Vifor (International) Ltd Vifor Pharma Ltd. Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner |
0 | $0 | 7,396,770 (Indirect) |
View |
2021-08-24 Option Award |
2021-08-26 6:18 pm |
N/A N/A |
Cara Therapeutics Inc. | CARA | Reilly Thomas Charles Chief Financial Officer |
5,334 | $0 | 5,334 (Direct) |
View |